Close Menu

NanoString

NEW YORK (GenomeWeb News) – NanoString Technologies reported after the close of the market Wednesday a 55 percent increase in fourth quarter revenues, driven by strong growth for its instruments.

A Pfizer research group, working with Seoul's Samsung Medical Center, has published a study demonstrating a multiplex method for detecting ALK, ROS1, and RET fusions in a single assay.

NanoString Technologies this week announced the publication of a study in Clinical Cancer Research showing that the PAM50 assay, on which its Prosig

NEW YORK (GenomeWeb News) – NanoString Technologies has priced the follow-on public offering of its common stock at $18.50 per share.

NEW YORK (GenomeWeb News) – NanoString Technologies said after the close of the market Tuesday that it has launched a follow-on public offering of $55 million of common stock.

Researchers at Massachusetts General Hospital have developed a proteomic assay using DNA-barcoded antibodies that can simultaneously measure in the range of 100 proteins at single-cell sensitivity.

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference continued here Wednesday with presentations from several life science tools and diagnostic firms.

NEW YORK (GenomeWeb News) – NanoString Technologies said after the close of markets Wednesday that it has secured an exclusive option from Massachusetts General Hospital to license intellectual property related to a method of multiplexed protein analysis using the company's nCounter Analysis Syst

NEW YORK (GenomeWeb News) - NanoString Technologies today reported unaudited fourth-quarter 2013 revenue of $10.1 million, representing 55 percent growth over the comparable period of 2012 and beating analyst estimates of $9.6 million.

NEW YORK (GenomeWeb News) – Shares of NanoString jumped 46 percent in December to lead a nearly 4 percent gain for the GenomeWeb Daily News Index for the month.

Pages

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.